Study to Assess the Effectiveness and Safety of Dhathri Fair Skin Cream in Skin Fairness, Black Spots and Dark Circles.

Phase 4

Completed

• Conditions: Health Condition 1: L814- Other melanin hyperpigmentationHealth Condition 2: L988- Other specified disorders of the skin and subcutaneous tissue

• Registration Number: CTRI/2013/05/003683
• Lead Sponsor: Dhathri Ayurveda Private Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

1. Healthy Male and female subjects aged between

18 and 35 years.

2. Subjects who can read, understand, give written informed consent form and who are willing to comply with the study protocol.

3. Subjects of skin grade III, IV, and V (Fitzpatrick Scale).

4. Subjects with any type of skin like oily, normal and dry.

5. Subjects having at least any one of the following: black spots, dark circles under eyes. (Minimum 5 subjects with black spots and Minimum 5 subjects with dark circles under eyes)

6. Subjects showing negative to sensitivity test.

7. Subject who has not participated in a similar investigation in the past four weeks.

8. Subjects having pigmentation freckles, pigmented demarcation lines, and uneven tone skin will also be included.

Exclusion Criteria

1. Women who are pregnant or lactating.

2. A known history or present condition of allergic response to any cosmetic products.

3. Subjects with a history of Insomnia or sleeplessness.

4. Subject having skin diseases (e.g. moderate to severe acne vulgaris face, psoriasis, active atopic dermatitis, melasma, which will interfere with the test readings.

5. Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study.

6. Systemic treatment of the skin that may change the state of the skin, in the previous 30 days.

7. Subjects not willing to discontinue other fairness/whitening/ brightening creams including vitamin A derivatives.

8. Subjects showing allergic reactions to any component of the tested products.

9. Subjects who has a history of intense sun exposure.

10. Chronic illness which may influence the cutaneous state of the skin.

11. Subject participating in any other cosmetic or therapeutic trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified